Embryo-derived peptide as a longevity-promoting agent: PreImplantation Factor (PIF)-based therapy for aging-associated diseases and Lifespan extension: Synthetic PreImplantation Factor (sPIF)  inhibits the interaction of DBC1 with PARP1, increases the PARP1 activity, promotes DNA repair, augments tolerance against radiation, cancer, and aging, via down-regulation of its target gene, 16/April/2019, 11.01 pm

"Help us make a difference by supporting our mission with your generous donation."

Spread the love


Spread the love
small_c_popup.png

Let's have a chat!

Sign-up for our newsletter to learn more about upcoming Genomediscovery Forums!